Cite
HARVARD Citation
Battaglini, M. et al. (2022). Evolution from a first clinical demyelinating event to multiple sclerosis in the REFLEX trial: Regional susceptibility in the conversion to multiple sclerosis at disease onset and its amenability to subcutaneous interferon beta‐1a. European journal of neurology. pp. 2024-2035. [Online].